BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3698245)

  • 1. Ventricular tachycardia in a young population without overt heart disease.
    Deal BJ; Miller SM; Scagliotti D; Prechel D; Gallastegui JL; Hariman RJ
    Circulation; 1986 Jun; 73(6):1111-8. PubMed ID: 3698245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.
    Lemery R; Brugada P; Bella PD; Dugernier T; van den Dool A; Wellens HJ
    Circulation; 1989 May; 79(5):990-9. PubMed ID: 2713978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram.
    Rahilly GT; Prystowsky EN; Zipes DP; Naccarelli GV; Jackman WM; Heger JJ
    Am J Cardiol; 1982 Sep; 50(3):459-68. PubMed ID: 6810685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic testing and follow-up of patients with aborted sudden death.
    Eldar M; Sauve MJ; Scheinman MM
    J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsustained ventricular tachycardia during programmed ventricular stimulation: criteria for a positive test.
    Platia EV; Reid PR
    Am J Cardiol; 1985 Jul; 56(1):79-83. PubMed ID: 4014044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular tachycardia: clinical and electrophysiologic characteristics.
    Buxton AE; Waxman HL; Marchlinski FE; Simson MB; Cassidy D; Josephson ME
    Circulation; 1983 Nov; 68(5):917-27. PubMed ID: 6137291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encircling endocardial resection with complete removal of endocardial scar without intraoperative mapping for the ablation of drug-resistant ventricular tachycardia.
    Landymore RW; Kinley CE; Gardner M
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):18-24. PubMed ID: 3965815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up.
    Olshansky B; Mazuz M; Martins JB
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):216-23. PubMed ID: 3968306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of endocardial and epicardial programmed stimulation for the induction of ventricular tachycardia.
    Dailey SM; Kay GN; Epstein AE; McGiffin DC; Kirklin JK; Plumb VJ
    J Am Coll Cardiol; 1989 Jun; 13(7):1608-12. PubMed ID: 2723273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
    Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
    Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular tachycardia in children.
    Rocchini AP; Chun PO; Dick M
    Am J Cardiol; 1981 May; 47(5):1091-7. PubMed ID: 7223656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular fibrillation in six adults without overt heart disease.
    Lemery R; Brugada P; Della Bella P; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1989 Mar; 13(4):911-6. PubMed ID: 2926043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.